VOLITIONRX LTD — Director's Dealing 2020

Aug 12, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2020-08-10

Reporting Person: Micallef Jacob Vincent (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-10	Common Stock	M	65000	$2.5	Acquired	151166	Direct
2020-08-10	Common Stock	F	55158	$3.5	Disposed	96008	Direct
2020-08-10	Common Stock	M	65000	$3	Acquired	161008	Direct
2020-08-10	Common Stock	F	60080	$3.5	Disposed	100928	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-10	Stock Option (Right to Buy)	$2.5	M	65000	Disposed	2020-08-18	Common Stock (65000)	Direct
2020-08-10	Stock Option (Right to Buy)	$3	M	65000	Disposed	2020-08-18	Common Stock (65000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	22000	Indirect
Common Stock	38113	Indirect

Footnotes

F1: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation as payment of the exercise price in a cashless exercise and to satisfy the tax withholding obligations of the Reporting Person. No shares were sold by the Reporting Person or VolitionRx in such cashless exercise transaction.

F2: The shares of common stock are held directly by Borlaug Limited. Dr. Micallef is a controlling director of Borlaug Limited and has voting and dispositive control over the shares of common stock held by Borlaug Limited.